Royalty Pharma
RPRX
#621
Rank
NZ$71.38 B
Marketcap
NZ$124.16
Share price
-0.01%
Change (1 day)
78.06%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): NZ$2.66

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is NZ$2.76. In 2025 the company made an earnings per share (EPS) of NZ$3.23 a decrease over its 2024 EPS that were of NZ$3.48.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.66-17.64%
2025NZ$3.23-7.1%
2024NZ$3.48
2020NZ$2.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
NZ$4.89 76.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.85 1,920.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$9.37 238.73%๐Ÿ‡บ๐Ÿ‡ธ USA